Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Hypertension and KRAS[original query] |
|---|
| Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program. BMC cancer 2016 16 412. Adenis Antoine, de la Fouchardiere Christelle, Paule Bernard, Burtin Pascal, Tougeron David, Wallet Jennifer, Dourthe Louis-Marie, Etienne Pierre-Luc, Mineur Laurent, Clisant Stéphanie, Phelip Jean-Marc, Kramar Andrew, Andre Thier |
| Treatment of Metastatic Colorectal Cancer Patients =75 Years Old in Clinical Practice: A Multicenter Analysis. PloS one 2016 11 (7): e0157751. Grande Roberta, Natoli Clara, Ciancola Fabrizio, Gemma Donatello, Pellegrino Arianna, Pavese Ida, Garufi Carlo, Di Lauro Luigi, Corsi Domenico, Signorelli Diego, Sperduti Isabella, Cortese Giada, Risi Emanuela, Morano Federica, Sergi Domenico, Signorelli Carlo, Ruggeri Enzo Maria, Zampa Germano, Russano Marco, Gamucci Tere |
| A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196. Oncotarget 2017 Sep 8 (41): 69651-69662. Leighl Natasha B, Tsao Ming-Sound, Liu Geoffrey, Tu Dongsheng, Ho Cheryl, Shepherd Frances A, Murray Nevin, Goffin John R, Nicholas Garth, Sakashita Shingo, Chen Zhuo, Kim Lucia, Powers Jean, Seymour Lesley, Goss Glenwood, Bradbury Penelope |
| Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension. American journal of medical genetics. Part A 2018 10 176 (11): 2523-2527. McDonell Laura M, Leung Gordon Ka-Chun, Daoud Hussein, Ip Janice, Chim Stella, Luk Ho Ming, Lan Lawrence, , Boycott Kym M, Chung Brian Hon-Y |
| Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer. Clinical lung cancer 2019 2 20 (3): e317-e328. Nokihara Hiroshi, Nishio Makoto, Yamamoto Noboru, Fujiwara Yutaka, Horinouchi Hidehito, Kanda Shintaro, Horiike Atsushi, Ohyanagi Fumiyoshi, Yanagitani Noriko, Nguyen Linh, Yaron Yifah, Borgman Anne, Tamura Tomohi |
| Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy. Frontiers in oncology 2020 8 10 1155. Bruera Gemma, D'Andrilli Antonio, Simmaco Maurizio, Guadagni Stefano, Rendina Erino Angelo, Ricevuto Enri |
| Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86). Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jan . Dhani Neesha C, Hirte Hal W, Wang Lisa, Burnier Julia V, Jain Angela, Butler Marcus O, Welch Stephen, Fleming Gini F, Hurteau Jean, Matsuo Koji, Matei Daniela, Jimenez Waldo, Johnston Carolyn, Cristea Mihaela, Tonkin Katia, Ghatage Prafull, Lheureux Stephanie, Mehta Anjali, Quintos Judy, Tan Qian, Kamel-Reid Suzanne, Ludkovski Olga, Tsao Ming-Sound, Wright John J, Oza Amit |
| Anatomic location of colorectal cancer presents a new paradigm for its prognosis in African American patients. PloS one 2022 17 (7): e0271629. Wang Donghai, Agrawal Raag, Zou Shuli, Haseeb M A, Gupta Raa |
| Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Hepatology (Baltimore, Md.) 2022 May . Zhou Jun, Sun Yongkun, Zhang Wen, Yuan Jiajia, Peng Zhi, Wang Wei, Gong Jifang, Yang Lin, Cao Yanshuo, Zhao Hong, Chen Chao, Wang Weifeng, Shen Lin, Zhou Aipi |
| Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survival. Frontiers in medicine 2023 2 10 1091634. Ottaiano Alessandro, Santorsola Mariachiara, Circelli Luisa, Perri Francesco, Cascella Marco, Sabbatino Francesco, Capuozzo Maurizio, Granata Vincenza, Zappavigna Silvia, Lombardi Angela, Scrima Marianna, Petrillo Nadia, Ianniello Monica, Casillo Marika, Gualillo Oreste, Nasti Guglielmo, Caraglia Michele, Savarese Giovan |
| Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107988. Akito Hata, Nobuyuki Katakami, Naoto Takase, Kayoko Kibata, Yuta Yamanaka, Motohiro Tamiya, Masahide Mori, Takashi Kijima, Satoshi Morita, Kazuko Sakai, Kazuto Nish |
- Page last reviewed:Feb 1, 2024
- Content source: